ATE531813T1 - System zur überwachung einer bakteriellen tumorbehandlung - Google Patents
System zur überwachung einer bakteriellen tumorbehandlungInfo
- Publication number
- ATE531813T1 ATE531813T1 AT02806289T AT02806289T ATE531813T1 AT E531813 T1 ATE531813 T1 AT E531813T1 AT 02806289 T AT02806289 T AT 02806289T AT 02806289 T AT02806289 T AT 02806289T AT E531813 T1 ATE531813 T1 AT E531813T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- tumor treatment
- progress
- bacteria
- monitoring bacterial
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0045—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent agent being a peptide or protein used for imaging or diagnosis in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
- A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0045—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent agent being a peptide or protein used for imaging or diagnosis in vivo
- A61K49/0047—Green fluorescent protein [GFP]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
- A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
- A61K49/0097—Cells, viruses, ghosts, red blood cells, viral vectors, used for imaging or diagnosis in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pathology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Radiology & Medical Imaging (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Rheumatology (AREA)
- Biotechnology (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34569901P | 2001-12-31 | 2001-12-31 | |
| PCT/US2002/041822 WO2003057007A2 (en) | 2001-12-31 | 2002-12-31 | System for monitoring bacterial tumor treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE531813T1 true ATE531813T1 (de) | 2011-11-15 |
Family
ID=23356109
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02806289T ATE531813T1 (de) | 2001-12-31 | 2002-12-31 | System zur überwachung einer bakteriellen tumorbehandlung |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20030161788A1 (de) |
| EP (1) | EP1461449B1 (de) |
| JP (1) | JP4350519B2 (de) |
| KR (2) | KR20110097841A (de) |
| CN (2) | CN1623001A (de) |
| AT (1) | ATE531813T1 (de) |
| AU (1) | AU2002367319B8 (de) |
| CA (1) | CA2470411C (de) |
| WO (1) | WO2003057007A2 (de) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1738649A (zh) * | 2001-07-09 | 2006-02-22 | 抗癌公司 | 用荧光蛋白作为标记物使感染成像 |
| EP1281767A3 (de) | 2001-07-31 | 2003-05-28 | Aladar A. Szalay | Lichtausstrahlende Mikroorganismen und Zellen für die Diagnose und Therapie von Tumoren |
| KR20110097841A (ko) * | 2001-12-31 | 2011-08-31 | 안티캔서, 인코포레이티드 | 박테리아 종양 치료의 모니터링 시스템 |
| EP1369491A1 (de) * | 2002-06-05 | 2003-12-10 | Aladar A. Szalay | Lichtemittierende Mikroorganismen und Zellen für die Diagnose und Therapie von Krankheiten assoziiert mit Wunden oder entzündetem Gewebe |
| US20030228261A1 (en) * | 2002-06-05 | 2003-12-11 | Aladar Szalay | Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue |
| WO2005047458A2 (en) | 2003-06-18 | 2005-05-26 | Genelux Corporation | Modified recombinant vaccina viruses and other microorganisms, uses thereof |
| US7155274B1 (en) | 2003-11-21 | 2006-12-26 | Imaging Diagnostic Systems, Inc. | Optical computed tomography scanner for small laboratory animals |
| EP1781096B1 (de) * | 2004-06-29 | 2016-02-24 | AntiCancer, Inc. | Prostatakarzinomselektive salmonella typhimurium auxotrophe |
| TW200819540A (en) | 2006-07-11 | 2008-05-01 | Genelux Corp | Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders |
| EP2242516A1 (de) | 2008-01-11 | 2010-10-27 | Genelux Corporation | Verfahren und zusammensetzungen zum nachweis von bakterien und zur behandlung von erkrankungen und störungen |
| US20130095072A1 (en) * | 2010-01-29 | 2013-04-18 | Anaeropharma Science, Inc. | Therapeutic agent for ischemic diseases |
| US9730968B2 (en) | 2008-04-17 | 2017-08-15 | Anaeropharma Science, Inc. | Therapeutic agent for ischemic diseases |
| WO2009140757A1 (en) | 2008-05-20 | 2009-11-26 | University Health Network | Device and method for fluorescence-based imaging and monitoring |
| EP2896695A3 (de) | 2010-01-29 | 2015-09-23 | Anaeropharma Science, Inc. | Transformationsplasmid |
| US8859256B2 (en) | 2011-10-05 | 2014-10-14 | Genelux Corporation | Method for detecting replication or colonization of a biological therapeutic |
| CN103146626B (zh) * | 2013-02-28 | 2014-12-31 | 南京华贞生物医药科技有限公司 | 一种治疗乳腺癌的基因工程菌及其构建方法和应用 |
| EP3171765B1 (de) | 2014-07-24 | 2021-09-01 | University Health Network | Sammlung und analyse von daten für diagnostische zwecke |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6251384B1 (en) * | 1997-04-28 | 2001-06-26 | Anticancer, Inc. | Metastasis models using green fluorescent protein (GFP) as a marker |
| WO2000074686A1 (en) * | 1999-06-09 | 2000-12-14 | Anticancer, Inc. | Modulators of methylation for control of bacterial virulence |
| CA2386806A1 (en) * | 1999-10-04 | 2001-04-12 | Vion Pharmaceuticals, Inc. | Non-invasive tumor imaging by tumor-targeted bacteria |
| CN1549859A (zh) * | 2001-01-29 | 2004-11-24 | 改进的荧光蛋白 | |
| CN1738649A (zh) * | 2001-07-09 | 2006-02-22 | 抗癌公司 | 用荧光蛋白作为标记物使感染成像 |
| EP1281767A3 (de) * | 2001-07-31 | 2003-05-28 | Aladar A. Szalay | Lichtausstrahlende Mikroorganismen und Zellen für die Diagnose und Therapie von Tumoren |
| KR20110097841A (ko) * | 2001-12-31 | 2011-08-31 | 안티캔서, 인코포레이티드 | 박테리아 종양 치료의 모니터링 시스템 |
| EP1781096B1 (de) * | 2004-06-29 | 2016-02-24 | AntiCancer, Inc. | Prostatakarzinomselektive salmonella typhimurium auxotrophe |
-
2002
- 2002-12-31 KR KR1020117013833A patent/KR20110097841A/ko not_active Ceased
- 2002-12-31 CA CA2470411A patent/CA2470411C/en not_active Expired - Fee Related
- 2002-12-31 JP JP2003557375A patent/JP4350519B2/ja not_active Expired - Fee Related
- 2002-12-31 AT AT02806289T patent/ATE531813T1/de active
- 2002-12-31 KR KR1020047010428A patent/KR101142380B1/ko not_active Expired - Lifetime
- 2002-12-31 EP EP02806289A patent/EP1461449B1/de not_active Expired - Lifetime
- 2002-12-31 WO PCT/US2002/041822 patent/WO2003057007A2/en not_active Ceased
- 2002-12-31 US US10/335,056 patent/US20030161788A1/en not_active Abandoned
- 2002-12-31 CN CNA028283902A patent/CN1623001A/zh active Pending
- 2002-12-31 CN CN2010102182345A patent/CN101869716B/zh not_active Expired - Fee Related
- 2002-12-31 AU AU2002367319A patent/AU2002367319B8/en not_active Ceased
-
2009
- 2009-04-13 US US12/422,863 patent/US20090249500A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN101869716B (zh) | 2013-12-11 |
| AU2002367319B2 (en) | 2008-02-28 |
| EP1461449A4 (de) | 2006-05-03 |
| US20030161788A1 (en) | 2003-08-28 |
| WO2003057007A3 (en) | 2003-11-06 |
| EP1461449A2 (de) | 2004-09-29 |
| AU2002367319A1 (en) | 2003-07-24 |
| CN1623001A (zh) | 2005-06-01 |
| WO2003057007A2 (en) | 2003-07-17 |
| US20090249500A1 (en) | 2009-10-01 |
| CA2470411A1 (en) | 2003-07-17 |
| CA2470411C (en) | 2015-07-07 |
| JP4350519B2 (ja) | 2009-10-21 |
| KR20040078659A (ko) | 2004-09-10 |
| KR20110097841A (ko) | 2011-08-31 |
| KR101142380B1 (ko) | 2012-05-18 |
| CN101869716A (zh) | 2010-10-27 |
| EP1461449B1 (de) | 2011-11-02 |
| JP2005521648A (ja) | 2005-07-21 |
| AU2002367319B8 (en) | 2008-03-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2003057007A3 (en) | System for monitoring bacterial tumor treatment | |
| ATE411399T1 (de) | Behandlung der huntington's krankheit mit epa | |
| EA201001695A1 (ru) | Применение эпотилона d для лечения заболеваний, связанных с тау-белком | |
| WO2011127211A3 (en) | Methods, system and apparatus for the detection, diagnosis and treatment of biological rhythm disorders | |
| NO20060027L (no) | Antistoffer mot bindevevsvekstfaktor | |
| CY1108765T1 (el) | ΑΓΩΓΗ ME ΑΝΤΙΣΩΜΑΤΑ ANTI-ErbB2 | |
| SI2441449T1 (sl) | Modulacija izražanja apolipoproteina c-iii | |
| TW200730211A (en) | System and method of delivering radiation therapy to a moving region of interest | |
| MX2009005849A (es) | Composiciones y metodos para tratar cancer con adn rico en cpg y cupredoxinas. | |
| EA201891507A1 (ru) | Кислая альфа-глюкозидаза усиленного действия для лечения болезни помпе | |
| DE602005026866D1 (de) | Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen | |
| WO2006014159A3 (en) | Methods of using regenerative cells in the treatment of musculoskeletal disorders | |
| EA201100413A1 (ru) | Способ лечения бактериальной инфекции | |
| MX2021009247A (es) | Metodos, sistemas y kits para tratar enfermedades inflamatorias que se dirigen a il18r1. | |
| BR0206251A (pt) | Métodos para avaliar e tratar leucemia | |
| TW200716224A (en) | Method of indentifying therapeutic targets for the treatment of vulvovaginal atrophy | |
| PL1778833T3 (pl) | Sposoby stosowania komórek regeneracyjnych w celu przyspieszania gojenia się ran | |
| TW200507840A (en) | Method of treating multiple myeloma | |
| EP2538963A4 (de) | Verfahren zur behandlung oder verhinderung von haarverlust oder zur verstärkung des haarwachstums | |
| DE50111407D1 (de) | Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen | |
| GB0304367D0 (en) | Methods for treating psoriasis | |
| WO2018176066A3 (en) | Cord blood therapy to treat chronic disease caused by l-form bacteria | |
| EP1143996A4 (de) | Methode zur behandlung von chronischen herzerkrankungen | |
| DE60334289D1 (de) | Dithiolopyrrolon-derivate zur behandlung von proliferativen störungen | |
| WO2003050247A3 (en) | Antisense modulation of mhc class ii transactivator expression |